CL2013003803A1 - Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones. - Google Patents

Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones.

Info

Publication number
CL2013003803A1
CL2013003803A1 CL2013003803A CL2013003803A CL2013003803A1 CL 2013003803 A1 CL2013003803 A1 CL 2013003803A1 CL 2013003803 A CL2013003803 A CL 2013003803A CL 2013003803 A CL2013003803 A CL 2013003803A CL 2013003803 A1 CL2013003803 A1 CL 2013003803A1
Authority
CL
Chile
Prior art keywords
pavilion
injury
dose
risk
reducing
Prior art date
Application number
CL2013003803A
Other languages
English (en)
Inventor
Rodrigo Torres Ciappa Carlos
Original Assignee
Dr Rodrigo Torres Ciappa Y Compania Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Rodrigo Torres Ciappa Y Compania Ltda filed Critical Dr Rodrigo Torres Ciappa Y Compania Ltda
Priority to CL2013003803A priority Critical patent/CL2013003803A1/es
Publication of CL2013003803A1 publication Critical patent/CL2013003803A1/es
Priority to PCT/CL2014/000085 priority patent/WO2015100512A1/es
Priority to US15/107,911 priority patent/US20170049766A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
CL2013003803A 2013-12-30 2013-12-30 Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones. CL2013003803A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2013003803A CL2013003803A1 (es) 2013-12-30 2013-12-30 Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones.
PCT/CL2014/000085 WO2015100512A1 (es) 2013-12-30 2014-12-23 Metodo y dosis para la administracion de dexmedetomidina, fentanilo y propofol, para la sedaci0n consciente en cirugias.
US15/107,911 US20170049766A1 (en) 2013-12-30 2014-12-23 Method and dose for the administration of dexmedetomidine, fentanyl and propofol for conscious sedation in surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013003803A CL2013003803A1 (es) 2013-12-30 2013-12-30 Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones.

Publications (1)

Publication Number Publication Date
CL2013003803A1 true CL2013003803A1 (es) 2014-05-23

Family

ID=53492874

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003803A CL2013003803A1 (es) 2013-12-30 2013-12-30 Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones.

Country Status (3)

Country Link
US (1) US20170049766A1 (es)
CL (1) CL2013003803A1 (es)
WO (1) WO2015100512A1 (es)

Also Published As

Publication number Publication date
US20170049766A1 (en) 2017-02-23
WO2015100512A1 (es) 2015-07-09

Similar Documents

Publication Publication Date Title
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
PT3004108T (pt) Derivados de pirazolo-pirrolidin-4-ona como inibidores de bet e a sua utilização no tratamento de doenças
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
ES1121155Y (es) Dispositivo y herramientas para la osteosintesis del esternon.
HK1223304A1 (zh) 包含二甲雙胍和二氫槲皮素的藥物組合及其用於治療癌症的用途
IL276733A (en) Use of Aribolin in cancer treatment
BR112015002706A2 (pt) niclosamida e seus derivados para uso no tratamento de tumores sólidos
HK1218879A1 (zh) 羥基酪醇及其衍生物的體內吸收促進劑及其利用
BR112014027953A2 (pt) nifuratel- (r), seu uso para o tratamento de infecções e síntese de nifuratel -(r) e -(s)
SG11201505930TA (en) Porcine parvovirus 5b, methods of use and vaccine
BR112017001384A2 (pt) composto para uso em tratamento anti-helmíntico
MA50358A (fr) Sémaglutide en thérapie médicale
HK1223041A1 (zh) 匹多莫德用於治療炎症相關疾病的用途
EP2985024A4 (en) THERAPEUTIC AGENT FOR SYSTEMIC BONE DISEASE AND USE THEREOF
FI20145861A (fi) Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä
GB2510477B (en) Formulations for use in the treatment of chronic fatigue and associated conditions, etc
GB201308753D0 (en) Compounds and their use in therapy
CL2013003803A1 (es) Método y dosis para la sedación consciente para el uso en cirugías dentro y fuera de pabellón disminuyendo el riesgo de lesiones.
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
CO7020917A2 (es) Cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi-metil)-naftalen-2-il-metil]-amonio para su uso en el tratamiento de distrofia muscular
TH1501007058A (th) อนุพันธ์ไพราโซโลไพร์โรลิดีน และการใช้งานของพวกมันในการบำบัดโรค
TH182881B (th) องค์ประกอบสำหรับการใช้ในการบำบัดภาวะภูมิแพ้
TH1601000714A (th) เอเจนต์สำหรับการส่งเสริมการดูดซึมไฮดรอกซีไทรอซอล และอนุพันธ์ของมันภายนอกกาย และการใช้อย่างเดียวกัน